Details of the Drug | DrugMAP

General Information of Drug (ID: DMB5CKZ)

Drug Name

AEB1102

Indication

Disease Entry	ICD 11	Status	REF
Arginase 1 deficiency	5C50.A2	Phase 2	[1]
Small-cell lung cancer	2C25.Y	Phase 1/2	[2]
Acute myeloid leukaemia	2A60	Phase 1	[2]
Myelodysplastic syndrome	2A37	Phase 1	[2]
Solid tumour/cancer	2A00-2F9Z	Phase 1	[2]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D08WQU

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT03378531) A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency (AEB1102). U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)